Sonova Holding

SOON.SW Large Cap

Healthcare · Medical Devices

Updated: Apr 5, 2026, 17:43 UTC

CHF 179.75

+0.5% today

52W: CHF 163.00 – CHF 283.50

52W Low: CHF 163.00 Position: 13.9% 52W High: CHF 283.50

🔗 Compare Brokers

Key Metrics

P/E Ratio

20.61x

Price-to-Earnings

Forward P/E

16.73x

Forward Price/Earnings

P/S Ratio

2.78x

Price-to-Sales

EV/EBITDA

13.69x

Enterprise Value/EBITDA

Div. Yield

245%

Annual dividend yield

Market Cap

$10.7B

Market Capitalization

Revenue Growth

-1%

YoY Revenue Growth

Profit Margin

13.53%

Net profit margin

ROE

22.17%

Return on Equity

Beta

1.14

Market sensitivity

Short Interest

—

% of float sold short

Avg. Volume

179,308

Average daily volume

Valuation Analysis

Signal

Fair

vs. S&P 500 avg P/E (24.7x)

Analyst Consensus

Hold

19 analysts

Avg. Price Target

CHF 219.30

+22% upside

Target Range

CHF 155.00 – CHF 310.00

About the Company

Sonova Holding AG manufactures and sells hearing care solutions for children and adults in Switzerland, the United States, rest of the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segment engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands. The Cochlear Implants segment is involved

Sector: Healthcare Industry: Medical Devices Country: Switzerland Employees: 18,035 Exchange: EBS